Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Neutraceutical Patent granted in Europe

Hamlet Pharma AB has secured patent protection in Europe for milk-based nutraceutical products that have been prepared using a mild process that generates nutraceutically beneficial complexes. This is the subject of European patent EP 3295953 B1. The patent is valid until  August 8, 2033.The patent is based on extensive academic research and discoveries made by researchers at Lund University. With this patent, Hamlet Pharma AB continues to expand it's intellectual property portfolio to cover further areas where its key products show benefit. ‘Bamlet is a molecule with beneficial effects.

Miika Soininen appointed to Ponsse Plc’s Management Team

Miika Soininen (38), student of technology, has been appointed Director of IT and Digital Services in Ponsse Plc’s Management Team. He will start in his new position on 1 December 2020. Soininen will report to Ponsse Plc’s President and CEO Juho Nummela, and his location will be in Vieremä.“The significance of digitalisation for the company’s operations has increased considerably, and data-based services will be a significant part of Ponsse’s future solutions and service range. The aim is to use the opportunities offered by digitalisation in developing Ponsse’s operations throughout the

Winter fun in sunny SouthWest Germany

Stuttgart, November 17, 2020 - Once lockdowns and restrictions have ended, why not get away to see and do something completely different? In winter, SouthWest Germany, the German federal state of Baden-Württemberg, offers sunshine, dazzling blue skies and experiences that are fun, romantic and adventurous. At night, Karlsruhe’s avenues are dotted with illuminated art installations. Europa-Park theme park keeps families busy and happy in winter, both outdoors and indoors, especially at Rulantica, the new water world. Stroll through the snowy Schwetzingen Palace Gardens or get the adrenaline

Recipharm and Medspray establish joint venture to exploit novel softmist technology for pharmaceutical applications

Recipharm AB (publ) (“Recipharm”), a leading contract development and manufacturing organisation (CDMO) and Medspray BV (“Medspray”), a manufacturer of high tech spray nozzles, announce today that they have agreed to establish a joint venture known as Resyca BV to develop and exploit the softmist spray nozzle technology for pharmaceutical applications. Under this agreement, Recipharm will invest EUR 15 million in return for 51% of the shares of Resyca. Medspray will transfer their softmist intellectual property relating to pharmaceutical applications into Resyca. The technology has the

New publication shows Cline’s gradient surfaces achieving faster and more efficient stem cell differentiation

In a new article published in the Journal of Biotechnology, Cline Scientific showed that gradient surfaces functionalized with Activin-A leads to improved, controllable and more efficient differentiation of stem cells compared to classical methods. Activin-A is an important biomolecule for the differentiation of stem cells into many different types of cells and organs. The team transformed induced pluripotent stem cells (iPSCs) into definitive endoderm (DE) which is the first step in generating many different cell linages and stem cell based applications. Cline's method not only allowed

Dustin publishes Annual and Corporate Responsibility Report for 2019/20

Dustin's full Annual and Corporate Responsibility Report for 2019/20 is now available in both English and Swedish at the company website, www.dustingroup.com.- The changes in behaviour, with an even greater focus on sales online and mobility have allowed us to accelerate the pace in implementing our strategy. Our customers want to purchase and manage their services digitally to an even greater extent, said Thomas Ekman President and CEO at Dustin. For additional information, please contact: Fredrik Sätterström, Head of Investor Relations fredrik.satterstrom@dustin.se, +46 705 10 10

TePe joins STEPS research programme for sustainable plastics

From autumn 2020 and on, TePe Oral Hygiene Products will be part in the STEPS research programme as an industrial partner. STEPS' vision is a society where plastics are sustainably produced, used and recycled in a circular economy. TePe’s commitment is in line with the company’s aim to promote sustainable development throughout the value chain.‘We are very excited to become part of this important collaboration between academia and industry. Together, we can be a driving force for the transition into a circular economy’, says Helena Ossmer Thedius, Marketing & Innovation Director at TePe.

Raute delivers state-of-the-art panel repairing technology for North America’s plywood industry

Raute Panel Repair Station R5 [Raute Panel Repair Station R5 is the first fully automated panel repair station] Raute Panel Repair Station R5 is the first fully automated panel repair station RAUTE CORPORATION PRESS RELEASE 17 NOVEMBER 2020 RAUTE DELIVERS STATE-OF-THE-ART PANEL REPAIRING TECHNOLOGY FOR NORTH AMERICA’S PLYWOOD INDUSTRY  Raute has launched a new and unique panel repair station and next-generation panel repairing line. Automatic panel repairing increases the cost efficiency of plywood production, ensures that the final quality of the panels is more uniform and

Lehto Group Plc: Managers' Transactions

Lehto Group PlcManagers’ TransactionsNovember 17, 2020 at 14.35 (EET)Lehto Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirementName: Höyhtyä, JuhaPosition: Other senior managerIssuer: Lehto Group OyjLEI: 743700YEHY9I3ZDHNX66 Notification type: INITIAL NOTIFICATIONReference number: 743700YEHY9I3ZDHNX66_20201117133248_2 ____________________________________________ Transaction date: 2020-11-16Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000081138Nature of the

Riksbank initiates corporate bond purchases via auctions

The Riksbank's purchases of corporate bonds have so far been made through a bilateral purchase procedure. On 2 December, the Riksbank will also begin purchasing corporate bonds via auctions. This means that the Riksbank's continued purchases will be made both through bilateral purchases and through auctions. The auctions will normally be held on Wednesdays every second week. The Riksbank will state which corporate bond or bonds it wishes to buy three days prior to each auction, and it is the Riksbank’s monetary policy counterparties that can participate and bid. Special terms and

Correction of previously published press release regarding Scandion Oncology’s rights issue (trading in BTAs)

The press release of 16 November 2020 (released at 08:31:34) stated incorrectly that the trading in BTAs in Scandion Oncology’s rights issue starts on 3 December 2020. The correct date for the start of trading in BTAs is 26 November 2020 and the trading will be ongoing until the Danish Business Authority has registered the rights issue and BTAs are converted to shares. Below is the correct preliminary timetable for the rights issue.Preliminary timetable for the rights issue Last day of trading in shares including 2020-11-20right to receive subscription rights:First day of trading in

Optomed’s January–September 2020 Interim Report to be published on 25 November 2020

Optomed Plc     Press Release    17 November 2020 at 14.00, Helsinki Optomed’s January–September 2020 Interim Report to be published on 25 November 2020 Optomed will publish its January–September 2020 Interim Report on 25 November 2020 approximately at 9.00 EET. A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest. The participants are requested to register for the call in advance by email to

Castellum in real estate transaction with the City of Gothenburg to enable future urban development

Castellum AB and the municipality of Gothenburg are carrying out a real estate transaction where Castellum is selling a property to the city in exchange for development rights in connection to Västlänken's future Station Centralen. “I see it as a typical example of a win-win, a good deal for both parties. We get to contribute to urban development in the city center while also offering the city an important piece of the puzzle in southern Gothenburg", comments Henrik Saxborn, CEO of Castellum AB.Due to intense development in the Frölunda-Högsbo-Sisjö area, the city has reviewed the needs

Quartiers acting rapidly on new restrictions

Quartiers, listed on Nasdaq First North in Stockholm, has adapted its operations on the basis of the new restrictions from the Spanish government, and has decided to keep its Boho Club (luxury hotel and restaurant on the Golden Mile in Marbella) facilities and the Quartiers Marbella Apartments hotel open. The company has introduced a number of initiatives designed to minimise the impact of the dip in revenue and has adopted measures to maximise cost savings.In summary, the effects of the restrictions introduced recently are: · Restaurants and all other non-essential businesses must

Aki Temmes appointed SVP, Business Control & Finance Operations at UPM

(UPM, Helsinki, 17 November 2020 at 14:00 EET) – Aki Temmes has been appointed Senior Vice President, Business Control & Finance Operations at UPM as of 1 January 2021. He will be based in Helsinki reporting to Tapio Korpeinen, CFO, UPM. Aki Temmes is currently Senior Vice President, UPM Timber. He joined UPM in 2003 and has previously held several Business Control leadership positions in UPM Biorefining and earlier in UPM’s paper business areas. Aki Temmes holds a Master’s degree in Finance from University of Tampere and an Executive MBA degree from Hanken School of Economics. [

Graduates get creative with new Stoke charity

Recent graduates have been competing to design the logo for a new creative project in Stoke-on-TrentCharitable organisation Stoke Creates  aims to be an engine for artistic, creative and cultural participation among children and young people in the Stoke and North Staffordshire city region. As a champion of emerging talent, Stoke Creates invited BA (Hons) Graphic Design  graduates from Staffordshire University to take part in a paid design competition to create their brand identity. Senior

BAMLET in non-prescription products

Hamlet Pharma is currently in discussions with major multinational companies on Letters of Intent including the evaluation- and development of processes for a potential, future commercial use of BAMLET in non-prescription and food products.BAMLET (bovine α-lactalbumin made lethal to tumour cells) is a molecular complex formed by bovine α-lactalbumin and oleic acid. The broad spectrum of benefits of BAMLET identified by the research group at Lund University and the development of a bovine derived complex to make use of BAMLET more broadly, present a very interesting opportunity also in non-

Pandox Hotel Market Day 2020 explores new trends in a changing hotel world

Pandox’s annual Hotel Market Day takes place today. The theme is “New trends in a changing hotel world”, which is explored with the help of prominent speakers and industry experts. The event will be webcasted live via www.pandox.se between 13:00 – 15:30 CET. “2020 has meant a new reality for Pandox and for the entire hospitality industry. Pandox is working with the framework Respond - steps to alleviate the acute crisis, Restart - plan for recovery and Reinvent - create insights into how the hotel market will change. With this year's Hotel Market Day – which for the first time is digital

Tokmanni Group Corporation: Managers' Transactions - Seppo Saastamoinen

Tokmanni Group Corporation     Managers' Transactions    17 November 2020 at 1:00 pmPerson subject to the notification requirementName: SAASTAMOINEN SEPPOPosition: Member of the Board/Deputy memberIssuer: TOKMANNI GROUP OYJLEI: 743700VMG6KWF0FW1560 Notification type: INITIAL NOTIFICATIONReference number: 743700VMG6KWF0FW1560_20201117105110_4 ____________________________________________ Transaction date: 2020-11-16Venue: BATS CHI-X EUROPE -BXE ORDER BOOKS (BATE)Instrument type: SHAREISIN: FI4000197934Nature of the transaction: ACQUISITION Transaction details(1)

Tokmanni Group Corporation: Managers' Transactions - Juha Blomster

Tokmanni Group Corporation     Managers' Transactions    17 November 2020 at 12:30 pmPerson subject to the notification requirementName: BLOMSTER JUHAPosition: Member of the Board/Deputy memberIssuer: TOKMANNI GROUP OYJLEI: 743700VMG6KWF0FW1560 Notification type: INITIAL NOTIFICATIONReference number: 743700VMG6KWF0FW1560_20201117094704_4 Transaction date: 2020-11-16Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000197934Nature of the transaction: ACQUISITION Transaction details(1): Volume: 1,748 Unit price: 14.3 EUR Aggregated transactions(

EQL Pharma receives a new order for consumables from a hospital region

In the spring, EQL Pharma announced an expansion of the product line to also include medical devices and consumables for healthcare, and a first order, in the form of protective equipment, was successfully delivered to a hospital region during the company's first financial quarter.Furthermore, EQL Pharma announced in July that it had received an order for consumables for delivery during the company's second and third quarters. The good cooperation with Sweden's regions has now led to an additional order for consumables with a sales value of just over SEK 14.4 million. Revenue is expected

2bind and Creoptix sign technology-service partnership

Zurich, Switzerland, and Regensburg, Germany, 17 November 2020 – Creoptix and 2bind have signed a technology-service partnership, which enables both parties to continue offering customers the highest quality research tools and help them accelerate their R&D. The collaboration supports 2bind to expand its service portfolio with the innovative WAVEsystem and provides Creoptix with a highly experienced partner as a certified service provider and beta-tester for future technology developments.2bind is a well-known Contract Research Organization (CRO) in the field of early drug discovery with

Ericsson estimates USD 31 trillion 5G consumer market by 2030

· 5G could drive up to USD 31 trillion in cumulative consumer revenue in the ICT industry by 2030 · Communications service providers (CSPs) could earn up to USD 3.7 trillion in cumulative 5G-enabled consumer revenues by 2030 · Augmented Reality (AR) could drive more than half of all consumer spending on immersive media by 2030The 5G consumer market could be worth USD 31 trillion by 2030 globally, according to the new Harnessing the 5G Consumer Potential report from Ericsson (NASDAQ: ERIC) ConsumerLab. The report estimates that communications service providers (CSPs) could earn USD 3.7

Board composition proposal by Boliden's Nomination Committee

Boliden’s Nomination Committee will propose to the Annual General Meeting of Shareholders in 2021 that Anders Ullberg is re-elected as Chairman of the Board. In other respects, re-election of the Board Members Helene Biström, Perttu Louhiluto, Michael G:son Löw, Elisabeth Nilsson and Pia Rudengren is proposed. Per Lindberg and Karl-Henrik Sundström are proposed as new Members of the Board. Tom Erixon has declined re-election.Per Lindberg has i.a. previously been CEO of BillerudKorsnäs and Epiroc. Karl-Henrik Sundström has i.a. previously been CFO of Ericsson and CEO of Stora Enso. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top